Aligos Therapeutics, Inc. (ALGS) stock
ALGSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/3010% below fair value
$2.10+0.12 (+6.06%)
Close on Nov 13, 2026Market cap $26.23MP/E –Yield –
Aligos Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Aligos Therapeutics's market cap was $13.47M on Nov 11, 2026, against $58.95M a year earlier. Over the last 5 years it ranged from $13.47M to $505.80M, with a median of $44.64M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.47M | -76.5% |
| 2025 | Dec 31, 2025 | $57.35M | -56.7% |
| 2024 | Dec 31, 2024 | $132.46M | +358.6% |
| 2023 | Dec 29, 2023 | $28.89M | -29.2% |
| 2022 | Dec 30, 2022 | $40.80M | -91.9% |
| 2021 | Dec 31, 2021 | $505.80M | +345.7% |
| 2020 | Dec 31, 2020 | $113.49M | – |
See a number that looks wrong?